Back
0

Psychopharmacology of Parkinson's Disease and Movement Disorders

Description: This quiz covers the psychopharmacology of Parkinson's disease and movement disorders, including the mechanisms of action, clinical uses, and adverse effects of various medications used in the treatment of these conditions.
Number of Questions: 15
Created by:
Tags: parkinson's disease movement disorders psychopharmacology dopamine anticholinergics levodopa carbidopa pramipexole ropinirole amantadine selegiline rasagiline mao-b inhibitors comt inhibitors
Start the Quiz
Attempted 0/15 Correct 0 Score 0
‹
›

Which of the following is the primary neurotransmitter affected in Parkinson's disease?

  1. Dopamine

  2. Serotonin

  3. Noradrenaline

  4. GABA

Show answer
Correct Option: A
Explanation:

Parkinson's disease is characterized by the degeneration of dopaminergic neurons in the substantia nigra, leading to a deficiency of dopamine in the brain.

What is the most commonly used medication for the treatment of Parkinson's disease?

  1. Levodopa

  2. Carbidopa

  3. Pramipexole

  4. Ropinirole

Show answer
Correct Option: A
Explanation:

Levodopa is the most commonly used medication for the treatment of Parkinson's disease. It is a dopamine precursor that is converted to dopamine in the brain.

What is the role of carbidopa in the treatment of Parkinson's disease?

  1. It reduces the peripheral conversion of levodopa to dopamine.

  2. It enhances the penetration of levodopa into the brain.

  3. It reduces the adverse effects of levodopa.

  4. It prolongs the duration of action of levodopa.

Show answer
Correct Option: A
Explanation:

Carbidopa is used in combination with levodopa to reduce the peripheral conversion of levodopa to dopamine, thereby increasing the amount of levodopa that reaches the brain.

Which of the following is a dopamine agonist used in the treatment of Parkinson's disease?

  1. Pramipexole

  2. Ropinirole

  3. Amantadine

  4. Selegiline

Show answer
Correct Option: A
Explanation:

Pramipexole and ropinirole are dopamine agonists that are used in the treatment of Parkinson's disease. They mimic the effects of dopamine in the brain.

What is the mechanism of action of amantadine in the treatment of Parkinson's disease?

  1. It increases the release of dopamine from presynaptic neurons.

  2. It blocks the reuptake of dopamine into presynaptic neurons.

  3. It inhibits the metabolism of dopamine.

  4. It protects dopaminergic neurons from degeneration.

Show answer
Correct Option: B
Explanation:

Amantadine is an anticholinergic agent that is used in the treatment of Parkinson's disease. It blocks the reuptake of dopamine into presynaptic neurons, thereby increasing the amount of dopamine available in the synapse.

Which of the following is a MAO-B inhibitor used in the treatment of Parkinson's disease?

  1. Selegiline

  2. Rasagiline

  3. Pramipexole

  4. Ropinirole

Show answer
Correct Option: A
Explanation:

Selegiline and rasagiline are MAO-B inhibitors that are used in the treatment of Parkinson's disease. They inhibit the breakdown of dopamine in the brain, thereby increasing the amount of dopamine available.

What is the mechanism of action of COMT inhibitors in the treatment of Parkinson's disease?

  1. They increase the release of dopamine from presynaptic neurons.

  2. They block the reuptake of dopamine into presynaptic neurons.

  3. They inhibit the metabolism of dopamine.

  4. They protect dopaminergic neurons from degeneration.

Show answer
Correct Option: C
Explanation:

COMT inhibitors are a class of medications that are used in the treatment of Parkinson's disease. They inhibit the metabolism of dopamine in the brain, thereby increasing the amount of dopamine available.

Which of the following is a common adverse effect of levodopa therapy in Parkinson's disease?

  1. Nausea and vomiting

  2. Dyskinesias

  3. Hallucinations

  4. Orthostatic hypotension

Show answer
Correct Option: B
Explanation:

Dyskinesias are involuntary movements that can occur as a side effect of levodopa therapy in Parkinson's disease.

What is the term used to describe the phenomenon of decreased effectiveness of levodopa over time in Parkinson's disease?

  1. Tardive dyskinesia

  2. Wearing-off effect

  3. Rebound effect

  4. Augmentation

Show answer
Correct Option: B
Explanation:

The wearing-off effect is the term used to describe the phenomenon of decreased effectiveness of levodopa over time in Parkinson's disease.

Which of the following is a potential strategy to manage the wearing-off effect of levodopa in Parkinson's disease?

  1. Increasing the dose of levodopa

  2. Adding a dopamine agonist

  3. Using a MAO-B inhibitor

  4. Using a COMT inhibitor

Show answer
Correct Option: B
Explanation:

Adding a dopamine agonist to levodopa therapy can help to manage the wearing-off effect in Parkinson's disease.

What is the term used to describe the phenomenon of involuntary movements that occur in the absence of levodopa therapy in Parkinson's disease?

  1. Tardive dyskinesia

  2. Wearing-off effect

  3. Rebound effect

  4. Augmentation

Show answer
Correct Option: C
Explanation:

The rebound effect is the term used to describe the phenomenon of involuntary movements that occur in the absence of levodopa therapy in Parkinson's disease.

Which of the following is a potential strategy to manage the rebound effect in Parkinson's disease?

  1. Reducing the dose of levodopa

  2. Adding a dopamine agonist

  3. Using a MAO-B inhibitor

  4. Using a COMT inhibitor

Show answer
Correct Option: A
Explanation:

Reducing the dose of levodopa can help to manage the rebound effect in Parkinson's disease.

What is the term used to describe the phenomenon of increased effectiveness of levodopa over time in Parkinson's disease?

  1. Tardive dyskinesia

  2. Wearing-off effect

  3. Rebound effect

  4. Augmentation

Show answer
Correct Option: D
Explanation:

Augmentation is the term used to describe the phenomenon of increased effectiveness of levodopa over time in Parkinson's disease.

Which of the following is a potential strategy to manage augmentation in Parkinson's disease?

  1. Increasing the dose of levodopa

  2. Adding a dopamine agonist

  3. Using a MAO-B inhibitor

  4. Using a COMT inhibitor

Show answer
Correct Option:
Explanation:

Reducing the dose of levodopa can help to manage augmentation in Parkinson's disease.

What is the term used to describe the phenomenon of involuntary movements that occur in response to a sudden reduction in the dose of levodopa in Parkinson's disease?

  1. Tardive dyskinesia

  2. Wearing-off effect

  3. Rebound effect

  4. Withdrawal dyskinesia

Show answer
Correct Option: D
Explanation:

Withdrawal dyskinesia is the term used to describe the phenomenon of involuntary movements that occur in response to a sudden reduction in the dose of levodopa in Parkinson's disease.

- Hide questions
ADVERTISEMENT

Find more quizzes from top tags

general knowledge
3615 Quizzes
119858 Questions
 technology
307 Quizzes
36705 Questions
 sports
963 Quizzes
19148 Questions
 history
1187 Quizzes
13475 Questions
 physics
598 Quizzes
13441 Questions
 biology
1160 Quizzes
12174 Questions
 science & technology
551 Quizzes
11015 Questions
 chemistry
490 Quizzes
9892 Questions
 maths
518 Quizzes
9324 Questions
 softskills
0 Quizzes
7131 Questions